‘LAUNCHING VACCINE FOR CHILDREN AGED 3+’

“Serum Institute of India has reached the trial phase of the vaccine for the children aged above three and should be ready within the next six months. We have also resumed exports to the international vaccine sharing programme COVAX. The supply of doses via COVAX is expected to increase substantially into Quarter 1, 2022. It’s a huge moment to begin exports again, for us, our partners at COVAX and the low- and middle-income countries we support. The world has largely depended on the low-cost, high-quality pharmaceuticals and vaccines that India has traditionally exported, so we are delighted to support the global vaccination effort once more. We will continue to work hand in hand with our global partners on our promising programmes in HPV and malaria and we will continue to fight health inequality globally by making vaccines more accessible and affordable.”

- ADAR POONAWALLA,

Chief Executive Officer, Serum Institute of India, Pune